1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Brivaracetam
Trade Name:
Brivlera
Manufacturer/Distributor:
UCB Canada Inc
Classification:
Antiepileptic agent
ATC Class:
N03AX - other antiepileptics
Status:
active
Notice of Compliance (yyyy/mm/dd):
2016/03/09
Date Marketed in Canada (yyyy/mm/dd):
2016/05/10
Presentation:
Tablet: 10 mg. DIN: 02452936
Tablet: 25 mg. DIN: 02452944
Tablet: 50 mg. DIN: 02452952
Tablet: 75 mg. DIN: 02452960
Tablet: 100 mg. DIN: 02452979
Oral solution: 10 mg/mL. DIN: 02452987
Injection: 10 mg/mL. DIN: 02452995
Comments:
Brivaracetam is approved as adjunctive therapy in management of parital-onset seizures in adult with epilepsy not adequately controlled with conventional therapy.
Back to:
Drug Product Listings 
